SFO requests law firm's documents into ENRC investigation
Dechert, the law firm that was investigating corporate governance issues at Eurasian Natural Resources Corporation (ENRC), has been sent a demand for documents from the Serious Fraud Office (SFO).
Dechert, the law firm that was investigating corporate governance issues at Eurasian Natural Resources Corporation (ENRC), has been sent a demand for documents from the Serious Fraud Office (SFO).
The SFO sent a Section 2a notice to the legal firm after it was fired by ENRC just weeks before it was due to unveil its findings of an investigation into the mining company's business practices in the Democratic Republic of Congo (DRC), sources told the Financial Times.
The notice, which the SFO uses as a way of securing documents, suggests the UK prospector is weighing the launch of a formal criminal inquiry into the FTSE 100 mining company.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It may also be a sign that the SFO may no longer feel it can trust the miner to investigate itself. ENRC was allowed to commission the independent investigation led by Dechert until late March.
"We can only use this power if the director finds reasonable grounds to suspect an offence has been committed involving serious or complex fraud or corruption," the SFO said in a statement about its Section 2 powers.
Section 2a in particular means the SFO can demand information at a pre-investigation stage when it suspects overseas bribery and corruption, the website added.
Dechert looked into ENRC's business practices including potentially fraudulent payments of at least $100m over four years. Another report into ENRC's African mines is pending.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published